| Wiegand, Ulrich (2009): Antiangiogenetische Therapie des humanen Pankreaskarzinoms durch ZD6474, ein neuartiger Inhibitor des vaskulären endothelialen Wachstumsfaktorrezeptor VEGF-R2 (KDR/FLK-1) Tyrosinkinase, nach orthotoper Implantation in die Nacktmaus. Dissertation, LMU München: Faculty of Medicine |
|
PDF
Wiegand_Ulrich.pdf 6Mb |
| Item Type: | Thesis (Dissertation, LMU Munich) | |
|---|---|---|
| Subjects: | 600 Technology, Medicine 600 Technology, Medicine > 610 Medical sciences and medicine | |
| Faculties: | Faculty of Medicine | |
| Language: | German | |
| Date Accepted: | 5. February 2009 | |
| 1. Referee: | Bruns, Christiane | |
| Persistent Identifier (URN): | urn:nbn:de:bvb:19-98926 | |
| MD5 Checksum of the PDF-file: | 4ae17dca51dc9e10b57b67639a775fa3 | |
| Signature of the printed copy: | 0700/UMD 13146 | |
| ID Code: | 9892 | |
| Deposited On: | 02. Apr 2009 09:31 | (UTC) |
| Last Modified: | 16. Oct 2012 08:26 | (UTC) |
Repository Staff Only: item control page